Aeglea Bio Therapeutics Inc - ESG Rating & Company Profile powered by AI
This assessment of Aeglea Bio Therapeutics Inc employs data points from across the web as well as from public disclosures by Aeglea Bio Therapeutics Inc. The page includes a Q&A table for Aeglea Bio Therapeutics Inc. This ESG rating covers 17 UN Sustainable Development Goals including: 'Quality Education', 'Reduced Inequalities' and 'Life below Water'.
Aeglea Bio Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.0, social score of 1.6 and governance score of 6.4.
3.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1234 | Quanterix Corp | 3.4 | Medium |
| 1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
| 1253 | Aeglea Bio Therapeutics Inc | 3.3 | Medium |
| 1253 | Calithera Biosciences Inc | 3.3 | Medium |
| 1253 | Cara Therapeutics Inc | 3.3 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Aeglea Bio Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Aeglea Bio Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Aeglea Bio Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Aeglea Bio Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Aeglea Bio Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Aeglea Bio Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Aeglea Bio Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. It also develops AGLE-177, a polyethylene glycol modified, which is in Phase I/II clinical trial for the treatment of patient with homocystinuria. In addition, the company's preclinical pipeline includes AGLE-325 for the treatment of cystinuria, as well as other research programs. The company was formerly known as Aeglea BioTherapeutics Holdings, LLC and changed its name to Aeglea BioTherapeutics, Inc. in March 2015. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas.